Literature DB >> 18592252

Is "watchful waiting" superior to surgery in children with neurofibromatosis type 1 presenting with extracranial and extramedullary tumor mass at diagnosis?

Wojciech Wozniak1, Marek W Karwacki.   

Abstract

AIM: The aim of this study was to compare aggressive surgery to "watchful waiting" in neurofibromatosis type 1 (NF-1) patients with benign peripheral nerve sheath tumors exceeding 150 cm(3).
MATERIALS AND METHODS: Observational study based on imaging studies and results of surgery was utilized.
RESULTS: Twenty-seven out of 114 NF-1 patients (mean age of 12.8 years) registered throughout the last 10 years were studied. The mean tumor volume was 237 cm(3). Among them, 18 (66%) underwent surgery. In 15 (84%), regrowth of a tumor was observed. Reoperation was necessary in five (27%). Two out of these five children (2/18, 11%) required a third operation. Stable process has been shown in the remaining nine children (34%) since diagnosis and in most operated children (10/18; 56%), besides the regrowth of the tumor.
CONCLUSIONS: "Watchful waiting" could be superior to aggressive surgery in selected patients without "oncological awareness" confirmed by imaging techniques (mostly magnetic resonance imaging). NF-1 children with gross tumor mass require lifetime imaging monitoring and complex medical evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18592252     DOI: 10.1007/s00381-008-0668-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  Peripheral neurogenic tumors: is the use of different types of imaging diagnostically useful?

Authors:  Nicolas Amoretti; Anne Grimaud; Etienne Hovorka; Patrick Chevallier; Christian Roux; Jean Noël Bruneton
Journal:  Clin Imaging       Date:  2006 May-Jun       Impact factor: 1.605

2.  The Norton-Simon hypothesis revisited.

Authors:  L Norton; R Simon
Journal:  Cancer Treat Rep       Date:  1986-01

3.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

4.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

Review 5.  Recent developments in neurofibromatosis type 1.

Authors:  Ming-Jen Lee; Dennis A Stephenson
Journal:  Curr Opin Neurol       Date:  2007-04       Impact factor: 5.710

6.  Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.

Authors:  J A McCaughan; S M Holloway; R Davidson; W W K Lam
Journal:  J Med Genet       Date:  2007-02-27       Impact factor: 6.318

Review 7.  Management of childhood malignant peripheral nerve sheath tumor.

Authors:  Andrea Ferrari; Gianni Bisogno; Modesto Carli
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 8.  Operative steps in management of benign nerve sheath tumors.

Authors:  Jonathon R Ball; Michael T Biggs
Journal:  Neurosurg Focus       Date:  2007-06-15       Impact factor: 4.047

Review 9.  Radiation induced peripheral nerve tumors: case series and review of the literature.

Authors:  Gelareh Zadeh; Chris Buckle; Patrick Shannon; Eric M Massicotte; Shun Wong; Abhijit Guha
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

10.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.